Libra Infusions Limited (DSE:LIBRAINFU)

Libra Infusions Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015
Net Income	1.58	5.76	6.09	5.82	4.31
Depreciation & Amortization	6.57	7.02	6.6	6.08	6.35
Other Operating Activities	0.67	-8.54	-10.49	58.8	-1.59
Change in Accounts Receivable	-4.28	-	-	-	-
Change in Inventory	2.59	-	-	-	-
Change in Accounts Payable	-1,562	-	-	-	-
Change in Income Taxes	-1.94	-	-	-	-
Change in Other Net Operating Assets	1,572	-	-	-	-
Operating Cash Flow	14.67	4.24	2.2	70.71	9.07
Operating Cash Flow Growth	245.82%	93.21%	-96.89%	679.99%	-
Capital Expenditures	-19.91	-3.93	-15.33	-10.86	-86.78
Sale of Property, Plant & Equipment	-	-	-	0.3	-
Investing Cash Flow	-19.91	-3.93	-15.33	-10.56	-86.78
Short-Term Debt Issued	8.66	-	-	-	-
Long-Term Debt Issued	2.87	6.24	-	-	238.32
Total Debt Issued	11.53	6.24	-	-	238.32
Short-Term Debt Repaid	-	-	-	-8.71	-159.87
Long-Term Debt Repaid	-0.91	-5.48	-7.78	-26.95	-
Total Debt Repaid	-0.91	-5.48	-7.78	-35.66	-159.87
Net Debt Issued (Repaid)	10.62	0.77	-7.78	-35.66	78.45
Common Dividends Paid	-0.01	-1.95	-1.4	-1.64	-0.73
Financing Cash Flow	10.61	-1.19	-9.19	-37.3	77.72
Miscellaneous Cash Flow Adjustments	0	-	-	-	-11.43
Net Cash Flow	5.37	-0.88	-22.32	22.85	-11.43
Free Cash Flow	-5.24	0.31	-13.13	59.85	-77.72
Free Cash Flow Margin	-2.66%	0.16%	-5.38%	25.13%	-27.08%
Free Cash Flow Per Share	-2.33	0.14	-5.83	26.57	-34.50
Cash Interest Paid	14.92	13.57	15.73	13.21	49.9
Cash Income Tax Paid	1.94	1.85	3.61	2.89	2
Levered Free Cash Flow	-9.58	-4.88	-21.88	49.08	-50.6
Unlevered Free Cash Flow	4.73	0.48	-14.67	57.33	-21.94
Change in Net Working Capital	-4.19	12.74	17.97	-47.99	-25.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.